Investing Profile

Vikram Bajaj

InvestorVC
Managing Director at Foresite Capital
Photo of Vikram Bajaj, Managing Director at Foresite Capital
cb
Foresite Capital Managing Director
$100K - $5.0M
$1.5M
11
$668M
CompanyStageDateRound SizeTotal Raised
Foresight Diagnostics
Series BJul 2024$33M
Series BApr 2023$59M
$110M
Co-investors: Shahram Seyedin-Noor (Civilization Ventures), Jim Tananbaum (Foresite Capital)
Spear Bio
Series AJul 2024$45M
$45M
Co-investors: David Singer (Maverick Capital)
Xaira Therapeutics
Series AApr 2024$1B
$1B
Co-investors: Scott Gottlieb (New Enterprise Associates (NEA)), Robert Nelsen (ARCH Venture Partners)
Alumis
Series CMar 2024$260M
Series AMay 2021$70M
$330M
Co-investors: Jim Tananbaum (Foresite Capital), Michael Rome (Foresite Capital), Richard Gaster (venBio)
Pleno
Series AOct 2022$40M
$40M
Co-investors: Andrew ElBardissi (Deerfield Management)
TenSixteen Bio
Series AJan 2022$40M
$40M
Co-investors: Krishna Yeshwant (GV (Google Ventures))
Interline Therapeutics
Series AMay 2021$60M
$60M
Co-investors: Jay Parrish (ARCH Venture Partners)
Tesseract Health
Series BApr 2021$80M
$80M
Co-investors: Jim Tananbaum (Foresite Capital)